🇺🇸 FDA
Patent

US 11278493

Ophthalmic formulations providing durable ocular lubrication

granted A61KA61K35/644A61K47/14

Quick answer

US patent 11278493 (Ophthalmic formulations providing durable ocular lubrication) held by ETERNATEAR, INC. expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ETERNATEAR, INC.
Grant date
Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/644, A61K47/14, A61K47/44, A61K9/0048